SAVA FY 2017 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SAVACassava Sciences, Inc.

$115M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$68,000

Operating Income

-$12M

Net Income

-$12M

EPS (Diluted)

$-1.82

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$11M

Total Liabilities

$1M

Stockholders' Equity

$10M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$68,000	-$58,000	-17.2%
Operating Income	-$12M	-$15M	+20.1%
Net Income	-$12M	-$15M	+19.8%